We’re excited to announce that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, an affiliate company of T-E PHARMA, will be presenting at the Investment Summit Session of BIO Asia–Taiwan 2025 conference. Time: 15:40-16:50 Roadshow, Wednesday, July 23, 2025 Venue: Room 701AB, 7F, TaiNEX2 Dr. Chu will share our latest breakthroughs in ADC product development … Continue reading Join our presentation at the BIO Asia-Taiwan 2025 Conference